Nearly 400k ‘immediately eligible’

ATAGI extends booster dose recommendation to 16- and 17-year-olds Community pharmacies can expect 16- and 17-year-olds to attend for their Pfizer booster dose after the Australian Technical Advisory Group on Immunisation (ATAGI) gave them the green light on Thursday. There are approximately 580,000 individuals in this age group in Australia, with 370,000 “immediately” eligible to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Clinical tips: Medicines affecting weight
Next New kidney PI warning